Introduction

Modafinil, a wakefulness-promoting agent, has garnered important consideration in recent times for its potential cognitive-enhancing results. Initially developed to treat narcolepsy and different sleep disorders, its off-label use for enhancing cognitive function and productivity has led to a burgeoning market. In Poland, the availability and purchase of modafinil current unique challenges and considerations, including legal regulations, accessibility, and the implications of its use.
The Pharmacology of Modafinil

Modafinil is labeled as a eugeroic, which refers to substances that promote wakefulness. Its exact mechanism of action remains not fully understood